BioCentury
ARTICLE | Financial News

BridgeBio raises $135M round

September 13, 2017 10:59 PM UTC

BridgeBio Pharma (Palo Alto, Calif.) raised $135 million in an undisclosed venture round led by new investor Viking Global Investors and existing investor KKR.

New investors AIG, Aisling Capital, Cormorant Capital and Janus Funds also participated alongside existing investor Perceptive Advisors...

BCIQ Company Profiles

BridgeBio Pharma Inc.